Autoantibodies directed against glutamate decarboxylase interfere with glucose-stimulated insulin secretion in dispersed rat islets.

Autor: Kamat V; Department of Medicine, University of Washington, Seattle, Washington, USA., Radtke JR; Department of Medicine, University of Washington, Seattle, Washington, USA., Hu Q; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, USA., Wang W; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, USA., Sweet IR; Department of Medicine, University of Washington, Seattle, Washington, USA., Hampe CS; Department of Medicine, University of Washington, Seattle, Washington, USA.
Jazyk: angličtina
Zdroj: International journal of experimental pathology [Int J Exp Pathol] 2022 Aug; Vol. 103 (4), pp. 140-148. Date of Electronic Publication: 2022 Mar 04.
DOI: 10.1111/iep.12437
Abstrakt: Islet autoantibodies, including autoantibodies directed against the 65kDa isoform of glutamate decarboxylase (GAD65Ab), are present in the majority of patients with newly diagnosed type 1 diabetes (T1D). Whereas these autoantibodies are historically viewed as an epiphenomenon of the autoimmune response with no significant pathogenic function, we consider in this study the possibility that they impact the major islet function, namely glucose-stimulated insulin secretion. Two human monoclonal GAD65Ab (GAD65 mAb) (b78 and b96.11) were investigated for uptake by live rat beta cells, subcellular localization and their effect on glucose-stimulated insulin secretion. The GAD65 mAbs were internalized by live pancreatic beta cells, where they localized to subcellular structures in an epitope-specific manner. Importantly, GAD65 mAb b78 inhibited, while GAD65 mAb b96.11 enhanced, glucose-stimulated insulin secretion (GSIS). These opposite effects on GSIS rule out non-specific effects of the antibodies and suggest that internalization of the antibody leads to epitope-specific interaction with intracellular machinery regulating insulin granule release. The most likely explanation for the alteration of GSIS by GAD65 Abs is via changes in GABA release due to inhibition or change in GAD65 enzyme activity. This is the first report indicating an active role of GAD65Ab in the pathogenesis of T1D.
(© 2022 Company of the International Journal of Experimental Pathology (CIJEP).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje